Résumé
Les cancers primitifs de l’urètre sont rares. Les données de la littérature sont limitées, et les recommandations sont de grades B et C. Un traitement conservateur peut être proposé pour les lésions localisées de l’urètre antérieur. Les lésions localement évoluées et celles de l’urètre postérieur relèvent d’une thérapie multimodale qui doit être discutée en réunion multidisciplinaire.
Abstract
Urethral carcinoma is a rare cancer. The published data on this topic are limited. Evidence-based information are of grade B and C. Sparing surgery can be an option for localized anterior tumors. For localized, advanced, and posterior tumors the treatment must be discussed by a multidisciplinary team, but the optimal treatment remains to be defined.
Références
Avances C, Lesourd A, Michel F, et al. (2009) Tumeurs primitives de l’urètre. Épidémiologie, diagnostic et anatomopathologie. Recommandations du comité de cancérologie de l’Association française d’urologie. Prog Urol 19: 165–169
Carroll PR, Dixon CM (1992) Surgical anatomy of the male and female urethra. Urol Clin North Am 19: 339–346
Champ CE, Hegarty SE, Shen X, et al. (2012) Prognostic factors and outcomes after definitive treatment of female urethral cancer: a population-based analysis. Urology 80: 374–381
Cheville JC, Dundore PA, Bostwick DG, et al. (1998) Transitional cell carcinoma of the prostate: clinicopathologic study of 50 cases. Cancer 82: 703–707
Cohen MS, Triaca V, Billmeyer B, et al. (2008) Coordinated chemoradiation therapy with genital preservation for the treatment of primary invasive carcinoma of the male urethra. J Urol 179: 536–541; discussion 541
Dalbagni G, Donat SM, Eschwege P, et al. (2001) Results of high dose rate brachytherapy, anterior pelvic exenteration and external beam radiotherapy for carcinoma of the female urethra. J Urol 166: 1759–1761
Dalbagni G, Zhang ZF, Lacombe L, et al. (1998) Female urethral carcinoma: an analysis of treatment outcome and a plea for a standardized management strategy. Br J Urol 82: 835–841
Dalbagni G, Zhang ZF, Lacombe L, et al. (1999) Male urethral carcinoma: analysis of treatment outcome. Urology 53: 1126–1132
Dayyani F, Pettaway CA, Kamat AM, et al. (2013) Retrospective analysis of survival outcomes and the role of cisplatin-based chemotherapy in patients with urethral carcinomas referred to medical oncologists. Urol Oncol 31: 1171–1177
Derksen JW, Visser O, de la Riviere GB, et al. (2013) Primary urethral carcinoma in females: an epidemiologic study on demographical factors, histological types, tumour stage and survival. World J Urol 31: 147–153
Dimarco DS, Dimarco CS, Zincke H, et al. (2004) Surgical treatment for local control of female urethral carcinoma. Urol Oncol 22: 404–409
Eble JNSG, Epstein JI, Sesterhenn IA (eds) (2004) Pathology and genetics of tumours of the urinary system and male genital organs. IARC World Health Organisation classification of tumours
Gakis G, Witjes JA, Comperat E, et al. (2013) EAU Guidelines on primary urethral carcinoma. Eur Urol 64: 823–830
Garden AS, Zagars GK, Delclos L (1993) Primary carcinoma of the female urethra. Results of radiation therapy. Cancer 71: 3102–3108
Gheiler EL, Tefilli MV, Tiguert R, et al. (1998) Management of primary urethral cancer. Urology 52: 487–493
Gofrit ON, Pode D, Pizov G, et al. (2009) Prostatic urothelial carcinoma: is transurethral prostatectomy necessary before bacillus Calmette-Guerin immunotherapy? BJU Int 103: 905–908
Gourtsoyianni S, Hudolin T, Sala E, et al. (2011) MRI at the completion of chemoradiotherapy can accurately evaluate the extent of disease in women with advanced urethral carcinoma undergoing anterior pelvic exenteration. Clin Radiol 66: 1072–1078
Hara I, Hikosaka S, Eto H, et al. (2004) Successful treatment for squamous cell carcinoma of the female urethra with combined radio- and chemotherapy. Int J Urol 11: 678–682
Hricak H, Secaf E, Buckley DW, et al. (1991) Female urethra: MR imaging. Radiology 178: 527–535
Iborra F, Rigaud J, Bastide C, et al. (2009) Prise en charge thérapeutique des tumeurs de l’urètre. Recommandations du comité de cancérologie de l’Association française d’urologie. Prog Urol 19: 170–175
Karnes RJ, Breau RH, Lightner DJ (2010) Surgery for urethral cancer. Urol Clin North Am 37: 445–457
Koontz BF, Lee WR (2010) Carcinoma of the urethra: radiation oncology. Urol Clin North Am 37: 459–466
Lont AP, Besnard AP, Gallee MP, et al. (2003) A comparison of physical examination and imaging in determining the extent of primary penile carcinoma. BJU Int 91: 493–495
Nigro ND, Vaitkevicius VK, Considine B Jr (1989) Dynamic management of squamous cell cancer of the anal canal. Invest New Drugs 7: 83–89
Palou Redorta J, Schatteman P, Huguet Perez J, et al. (2006) Intravesical instillations with bacillus Calmette-Guerin for the treatment of carcinoma in situ involving prostatic ducts. Eur Urol 49: 834–838; discussion 838
Petralia G, Villa G, Scardino E, et al. (2008) Local staging of penile cancer using magnetic resonance imaging with pharmacologically induced penile erection. Radiol Med 113: 517–528
Rabbani F (2011) Prognostic factors in male urethral cancer. Cancer 117: 2426–2434
Smith Y, Hadway P, Ahmed S, et al. (2007) Penile-preserving surgery for male distal urethral carcinoma. BJU Int 100: 82–87
Swartz MA, Porter MP, Lin DW, et al. (2006) Incidence of primary urethral carcinoma in the United States. Urology 68: 1164–1168
Weghaupt K, Gerstner GJ, Kucera H (1984) Radiation therapy for primary carcinoma of the female urethra: a survey over 25 years. Gynecol Oncol 17: 58–63
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Iborra, F., Murez, T., Millet, I. et al. Les cancers primitifs de l’urètre. Oncologie 16, 187–192 (2014). https://doi.org/10.1007/s10269-014-2387-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10269-014-2387-x